Literature DB >> 29854163

Replicability, Reproducibility, and Agent-based Simulation of Interventions.

R Stanley Hum1, Samantha Kleinberg2.   

Abstract

Secondary use of medical data and use of observational data for causal inference has been growing. Yet these data bring many challenges such as confounding due to unobserved variables and variation in medical processes across settings. Further, while methods exist to handle some of these problems, researchers lack ground truth to evaluate these methods. When a finding is not replicated across multiple sites, it is unknown whether this is a failure of an algorithm, a genuine difference between populations, or an artifact of structural differences between the sites. We show how agent-based simulation of medical interventions can be used to explore how bias, error, and variation across settings affect inference. Our approach enables users to model not only interventions and outcomes, but also the complex interaction between patients with different risks of mortality and providers with different observed and latent treatment effects. Ultimately we propose that such simulations can be used to better evaluate the behavior of new methods with known ground truth and better calculate sample size for EHR-based studies.

Entities:  

Mesh:

Year:  2018        PMID: 29854163      PMCID: PMC5977631     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  19 in total

1.  CONSORT statement: extension to cluster randomised trials.

Authors:  Marion K Campbell; Diana R Elbourne; Douglas G Altman
Journal:  BMJ       Date:  2004-03-20

2.  Drug development: Raise standards for preclinical cancer research.

Authors:  C Glenn Begley; Lee M Ellis
Journal:  Nature       Date:  2012-03-28       Impact factor: 49.962

3.  The Assessment, Monitoring, and Enhancement of Treatment Fidelity In Public Health Clinical Trials.

Authors:  Belinda Borrelli
Journal:  J Public Health Dent       Date:  2011       Impact factor: 1.821

4.  Portability of an algorithm to identify rheumatoid arthritis in electronic health records.

Authors:  Robert J Carroll; Will K Thompson; Anne E Eyler; Arthur M Mandelin; Tianxi Cai; Raquel M Zink; Jennifer A Pacheco; Chad S Boomershine; Thomas A Lasko; Hua Xu; Elizabeth W Karlson; Raul G Perez; Vivian S Gainer; Shawn N Murphy; Eric M Ruderman; Richard M Pope; Robert M Plenge; Abel Ngo Kho; Katherine P Liao; Joshua C Denny
Journal:  J Am Med Inform Assoc       Date:  2012-02-28       Impact factor: 4.497

Review 5.  Defining a reference set to support methodological research in drug safety.

Authors:  Patrick B Ryan; Martijn J Schuemie; Emily Welebob; Jon Duke; Sarah Valentine; Abraham G Hartzema
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

6.  A time-indexed reference standard of adverse drug reactions.

Authors:  Rave Harpaz; David Odgers; Greg Gaskin; William DuMouchel; Rainer Winnenburg; Olivier Bodenreider; Anna Ripple; Ana Szarfman; Alfred Sorbello; Eric Horvitz; Ryen W White; Nigam H Shah
Journal:  Sci Data       Date:  2014-11-11       Impact factor: 6.444

7.  Reproducible Research Practices and Transparency across the Biomedical Literature.

Authors:  Shareen A Iqbal; Joshua D Wallach; Muin J Khoury; Sheri D Schully; John P A Ioannidis
Journal:  PLoS Biol       Date:  2016-01-04       Impact factor: 8.029

8.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

9.  Assessing fidelity to treatment delivery in the ICONS (Identifying Continence OptioNs after Stroke) cluster randomised feasibility trial.

Authors:  Brigit M Chesworth; Michael J Leathley; Lois H Thomas; Christopher J Sutton; Denise Forshaw; Caroline L Watkins
Journal:  BMC Med Res Methodol       Date:  2015-08-21       Impact factor: 4.615

Review 10.  Sample size calculations in pediatric clinical trials conducted in an ICU: a systematic review.

Authors:  Stavros Nikolakopoulos; Kit C B Roes; Johanna H van der Lee; Ingeborg van der Tweel
Journal:  Trials       Date:  2014-07-08       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.